KATIE NEAL: Open Payments
NPI 1649795766 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 17 payments from 8 companies in 2025. Trend: 2023 $326 · 2024 $668 · 2025 $421
Food & beverage: $252Education: $169
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $188 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| LNHC, Inc | 1 | $14 |
Products named: TREMFYA, DUPIXENT, Rhapsido, DYSPORT, Zoryve, ZELSUVMI.
Industry payments across IN — which companies pay providers there.
